Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signalingAnnika De Sousa Linhares, Peter Steinberger, Christine Häfner et al.|Scientific Reports|2019Cited by 196
Enhanced and long term immunogenicity of a Her-2/neu multi-epitope vaccine conjugated to the carrier CRM197 in conjunction with the adjuvant MontanideJoshua Tobias, Ursula Wiedermann, Joanna Jasińska et al.|BMC Cancer|2017Cited by 44